跳至主要内容
临床试验/DRKS00033413
DRKS00033413尚未招募Unknown

The Effect of neuromuscular electrical stimulation (NMS) and botulinum neurotoxin on facial movement disorders

Klinik für Neurologie, Universitätsklinikum Jena0 个研究点目标入组 40 人开始时间: 2024年1月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • – Patients with facial movement disorders, regardless of whether symptoms have improved from previous botulinum toxin injections
  • – The effects of previous treatments, including but not limited to botulinum toxin injection, must have completely resolved at the time of inclusion
  • – Signed and dated consent form from the study participant before carrying out study-specific measures

排除标准

  • – Lack of compliance with the inclusion criteria
  • – Patients suffering from neurodegenerative diseases
  • – Severe depression, i.e. = 20 according to the Beck Depression Inventory (BDI)
  • – Mental or psychiatric illnesses
  • – Pregnant or breastfeeding women
  • – Carrier of an active medical implant
  • – Known allergies or intolerances to materials used in this study
  • – Concurrent participation in other drug or medical device studies that could affect the results of this clinical trial

研究者

发起方
Klinik für Neurologie, Universitätsklinikum Jena

相似试验